Medication Adherence Clinical Trials
2 recruiting trials for Medication Adherence. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Medication Adherence clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University of California, San Diego (1), University of Malaya (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Acceptance and Commitment Therapy (ACT) (behavioral, 1 trial), followed by Body weight circuit training, Empathetic social support.
Track Medication Adherence trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Women Focused Encounters for Resilience Independence Strength and Eudaimonia
The goal of this combination Type 1 hybrid and observational study is to evaluate the impact of a peer delivered intervention of acceptance and commitment therapy (ACT) + exercise...
Multilevel Ecological and COM-B Determinants of Medication Adherence in Adults With Diabetes
This observational study aims to understand why some adults with diabetes find it difficult to take their medicines as prescribed. Medication adherence is essential for...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Medication Adherence, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Medication Adherence, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Medication Adherence, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.